Prescribing overview
Advantage Multi products have species-specific moxidectin concentrations and parasite claims. Dog tubes must never be substituted for cat tubes; the ferret indication uses only the 0.4 mL cat presentation.
Key prescribing checks
- The dog product must not be used on cats. Neither product is an oral medicine; prevent ingestion and follow species-specific application and human-contact precautions.
- Confirm species, current weight, minimum age, heartworm assessment and intended parasites before dispensing. Do not infer tick coverage from flea or heartworm claims.
- The cat/ferret label excludes sick or debilitated animals and underweight cats. Review the current label when patient health or prior preventive use has changed.
Uses by species
Approval and evidence apply to the named product, species, route and indication. An extra-label use requires its own prescribing assessment; a human indication is not an animal approval.
Dogs
FDA-approved dog-product indicationsHeartworm prevention; circulating microfilariae; fleas; sarcoptic mange; specified intestinal nematodes
10% imidacloprid/2.5% moxidectin.
Use / indication source ↗Cats; ferrets
FDA-approved species-specific indicationsHeartworm prevention and fleas; cats additionally labeled ear mites and specified roundworms/hookworms
10% imidacloprid/1% moxidectin.
Use / indication source ↗Pharmacology & pharmacokinetics
Mechanism and clinical role
Imidacloprid is a chloronicotinyl insecticide; moxidectin is a macrocyclic lactone endectocide.
Absorption, distribution, metabolism and elimination
No quantitative species-specific PK summary is supplied by these reviewed labels.
SAFETY REFERENCE · PRODUCT & SPECIES SPECIFIC
Contraindications & cautions
Contraindications identify circumstances where the source says a product should not be used. Precautions call for assessment or monitoring. Interactions identify combinations to review. They are distinct categories; this summary does not replace a full interaction check or the current product label.
Advantage Multi for Dogs
U.S. dog topical solution containing 2.5% moxidectin.
Contraindications · when not to use
- Do not administer orally or use on cats.
Precautions & monitoring
- Prevent licking; ingestion can be especially severe in avermectin-sensitive dogs. Review heartworm status and reproductive/young-patient safety limits.
Advantage Multi for Cats
U.S. cat topical solution containing 1% moxidectin; specified cat-size presentation also labeled for ferrets.
Contraindications · when not to use
- No formal contraindications section is supplied; species-specific warnings still restrict use.
Precautions & monitoring
- Do not use on sick/debilitated cats or ferrets, underweight cats, or cats below nine weeks/two pounds. Prevent ingestion; reproductive safety is unestablished. Ferret eligibility requires the full label.
Current DailyMed ferret text calls for risk-benefit assessment below two pounds; manufacturer web summary says do not use below two pounds. Refer to the complete current product label.
Safety sources checked: . Selected label information; independent veterinary or veterinary-pharmacy review remains pending. A label for dogs, cats, horses or humans does not establish safety for another species.
Adverse effects
Application-site reactions, vomiting, salivation and neurologic signs are reported; ingestion can cause serious toxicity.
These are selected source-reported effects, not incidence estimates or an exhaustive list. Spontaneous postmarketing reports do not by themselves establish frequency or causality.
Dosing & administration
| Species & indication | Labeled regimen | Eligibility & source |
|---|---|---|
| Dogs ≥7 weeks, ≥3 lbHeartworm prevention/fleasAdvantage Multi for Dogs | Minimum imidacloprid 10 mg/kg + moxidectin 2.5 mg/kg Topical skin · Monthly Heartworm prevention: start 1 month before mosquito exposure, continue until 1 month after last exposure | Entire weight-band tube; >110 lb use appropriate combination. No oral administration or cat use. Verify full dosing label ↗ |
| Cats ≥9 weeks, ≥2 lbHeartworm prevention/fleasAdvantage Multi for Cats | Minimum imidacloprid 10 mg/kg + moxidectin 1 mg/kg Topical skin · Monthly Heartworm prevention: 1 month before through 1 month after mosquito exposure, or year-round | Whole weight-band tube; >18 lb use appropriate combination. Verify full dosing label ↗ |
| Ferrets 2–4.4 lbHeartworm prevention/fleasAdvantage Multi for Cats 0.4 mL only | Entire 0.4 mL tube (40 mg imidacloprid/4 mg moxidectin) Topical skin · Monthly Heartworm prevention: 1 month before through 1 month after mosquito exposure, or year-round | Below 2 lb requires risk–benefit assessment; efficacy above 4.4 lb unestablished. Verify full dosing label ↗ |
Other parasite indications have separate instructions; this table does not supply those regimens.
Extra-label prescribing and food-animal residue requirements are separate from labeled regimens. FDA extra-label-use guidance ↗
Drug & supplement interactions
This is a selected interaction reference, not an automated or comprehensive combination checker. Reconcile prescription drugs, nonprescription products, supplements and recent treatment changes.
Advantage Multi for Dogs
U.S. dog topical solution containing 2.5% moxidectin.
- Safety with same-day heartworm adulticide administration has not been evaluated.
Monitoring
Assess heartworm status and current weight; review neurologic signs after exposure.
Client counseling
Prevent licking for 30 minutes; separate treated animals. Children: avoid dog sites 2 hours, cat/ferret sites 30 minutes.
This section supports the veterinary team's discharge discussion; it does not replace the product’s Client Information Sheet where one is required.
Storage & handling
Cat/ferret product: 4–25°C; avoid excessive heat/cold.
Brands, formulations & ingredient identity
Active ingredients
Imidacloprid · Moxidectin
Advantage Multi for Dogs and Advantage Multi for Cats contain the same named actives but have different product instructions and moxidectin concentrations. Do not substitute the dog tube for the cat product.
The small-cat product has a specific ferret indication. This does not make all cat weight-band tubes interchangeable for ferrets.
Shared ingredients do not establish interchangeable concentrations, routes, release properties, species labeling or regional availability.
Advantage Multi for Dogs
- Formulation
- Topical solution
- Label / product scope
- Dogs
Dog formulation; contraindicated on cats.
Product label / source ↗Advantage Multi for Cats
- Formulation
- Topical solution
- Label / product scope
- Cats · Ferrets
Ferret authorization applies specifically to the 5.1–9 lb cat-size presentation and its label instructions.
Product label / source ↗References & review status
Clinical reference updated October 16, 2026. Independent veterinary or veterinary-pharmacy review not yet completed. Evidence gaps remain explicitly identified; this page does not claim equivalence to a comprehensive, professionally reviewed veterinary formulary.